Background Anti-cancer therapy is often a cause of premature ovarian insufficiency and
infertility since the ovarian follicle reserve is extremely sensitive to the effects of …

Enhanced long-term survival rates of young women with cancer and advances in
reproductive medicine and cryobiology have culminated in an increased interest in fertility …

Nanoencapsulation/nanocarrier systems like nanoemulsions, nanoliposomes, solid lipid
nanoparticles, biopolymeric nanocarriers, nature-inspired nanocapsules, have been shown …

Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …

Anti-cancer therapy, particularly chemotherapy, damages ovarian follicles and promotes
ovarian failure. The only pharmacological means for protecting the ovaries from …

Recent advances in our understanding of the mechanisms underlying the impact of cytotoxic
drugs on the ovary have opened up new directions for the protection of the ovary from …

Chemo-and radiation therapies used to treat cancer can have the unintended effect of
making patients infertile. Clinically established fertility preservation methods, such as egg …

Hematologic malignancies (HMs) pose a serious threat to patients' health and life, and the
five-year overall survival of HMs remains low. The lack of understanding of the pathogenesis …

As the number of young cancer survivors increases, quality of life after cancer treatment is
becoming an ever more important consideration. According to a report from the American …

Survival rates in oncological patients have been steadily increasing in recent years due to
the greater effectiveness of novel oncological treatments, such as radio-and chemotherapy …